2020年12月最新中科院JCR期刊分区数据【基础版、升级版(试行)】均已更新,欢迎查询使用! 如果您对期刊系统有任何需求或者问题,欢迎 反馈给我们。
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CANCER LETTERS CANCER LETT1. LetPub助力作者发表在《CANCER LETT》上的文章案例,致谢部分提及LetPub---3篇 | |||||||||||||||||||||
期刊ISSN | 0304-3835 | 微信扫码收藏此期刊 | ||||||||||||||||||||
E-ISSN | 1872-7980 | |||||||||||||||||||||
2019-2020最新IF | 点击查看(由greensci.net提供,推荐使用谷歌浏览器 - 2020年 New!) 点击查看(由scijournal.org提供 - 2019年旧版) | |||||||||||||||||||||
2019-2020自引率 | 2.40%登录查看自引率趋势图 | |||||||||||||||||||||
h-index | 161 | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/506050/description#description | |||||||||||||||||||||
期刊投稿网址 | http://ees.elsevier.com/can/default.asp?acw=3 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000 | |||||||||||||||||||||
出版商 | Elsevier Ireland Ltd | |||||||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
出版国家或地区 | NETHERLANDS | |||||||||||||||||||||
出版周期 | Biweekly | |||||||||||||||||||||
出版年份 | 1975 | |||||||||||||||||||||
年文章数 | 426登录查看年文章数趋势图 | |||||||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 ( 2021年1月发布版) | 不在预警名单中 | |||||||||||||||||||||
中科院SCI期刊分区 ( 2020年12月最新基础版) | 登录查看中科院JCR分区趋势图
| |||||||||||||||||||||
中科院SCI期刊分区 ( 2020年12月最新升级版) |
| |||||||||||||||||||||
中科院SCI期刊分区 ( 2020年1月旧的升级版) |
| |||||||||||||||||||||
SCI期刊coverage | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0304-3835%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均2.7个月 来源Elsevier官网: 平均3.3周 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 约52.27% | |||||||||||||||||||||
在线出版周期 | 来源Elsevier官网: 平均8.3周 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
登录查看自引率趋势图 |
登录查看中科院JCR分区趋势图 |
登录查看年文章数趋势图 |
中国学者近期发表的论文 | |
1. | Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer Author: Chunjuan Zhao, Tao Tao, Longyan Yang, Qiong Qin, Ying Wang, Hua Liu, Ran Song, Xiaomei Yang, Qiqi Wang, Siyu Gu, Ying Xiong, Dong Zhao, Songlin Wang, Duiping Feng, Wen G. Jiang, Jun Zhang, Junqi He Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.043 DOI |
2. | Corrigendum to “GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer” [Cancer Lett. 380 (2) (2016 Oct 1) 434–41] Author: Jiangning Gu, Di Wang, Jiaqiang Zhang, Yi Zhu, Ying Li, Hao Chen, Minmin Shi, Xuelong Wang, Baiyong Shen, Xiaxing Deng, Qian Zhan, Gang Wei, Chenghong Peng Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.031 DOI |
3. | Corrigendum to ‘High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells’ [Cancer Lett. 447 (2019) 164–173] Author: Zhaoduan Liang, Yanyan Li, Ye Tian, Huanling Zhang, Wenxuan Cai, Anan Chen, Lin Chen, Yifeng Bao, Bo Xiang, Heping Kan, Yi Li Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.026 DOI |
4. | DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell Author: Jing Luo, Kaichao Liu, Yu Yao, Qi Sun, Xiufen Zheng, Biqing Zhu, Quanli Zhang, Lin Xu, Yi Shen, Binhui Ren Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.045 DOI |
5. | Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation Author: Hongjun Xie, Tianjie Liu, Jiaqi Chen, Zhao Yang, Shan Xu, Yizeng Fan, Jin Zeng, Yule Chen, Zhenkun Ma, Yang Gao, Dalin He, Lei Li Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.044 DOI |
6. | Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion Author: Dong Wang, Li Yang, Dongli Yue, Ling Cao, Lifeng Li, Dan Wang, Yu Ping, Zhibo Shen, Yujia Zheng, Liping Wang, Yi Zhang Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.040 DOI |
7. | The μ-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma Author: Yi Li, Gang Li, Tao Tao, Xing Kang, Chang Liu, Xu Zhang, Chunyi Wang, Chong Li, Xiangyang Guo Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.038 DOI |
8. | Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging Author: Shengnan Liu, Yang Du, He Ma, Qian Liang, Xu Zhu, Jie Tian Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.037 DOI |
9. | HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma Author: Haotian Wang, Rujiang Jia, Tiansuo Zhao, Xin Li, Mingxiao Lang, Chungen Lan, Hongwei Wang, Zengxun Li, Bodong Zhou, Liangliang Wu, Yan Sun, Xiuchao Wang, He Ren, Jihui Hao Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.036 DOI |
10. | Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis Author: Liang Guo, Xiang Cheng, Hongyu Chen, Changguo Chen, Shuai Xie, Min Zhao, Dan Liu, Que Deng, Yanjun Liu, Xiaomeng Wang, Xintian Chen, Jiangong Wang, Zhaoyang Yin, Siyong Qi, Jiangping Gao, Yuanfang Ma, Ning Guo, Ming Shi Journal: CANCER LETTERS, 2019, Vol., , DOI:10.1016/j.canlet.2019.03.032 DOI |
|
|
首页 上一页 1 下一页 尾页 (去 | |
以上SCI期刊相关数据和信息来源于网络,仅供参考。 | |
同领域作者分享投稿经验:共15条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 人才招聘
© 2010-2021 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公安备案号:31010402006960
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451